Lysosomal Acid Lipase Deficiency

2

Review clinical trials related to Lysosomal Acid Lipase Deficiency. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Lysosomal Acid Lipase Deficiency in Risk Groups

A multicenter real-world observational study of the prevalence, diagnostic pathways, and clinical characteristics of lysosomal acid lipase deficiency in pediatric and adolescent risk groups in the Russian Federation (HELIOS)

Participants needed: 1,200
Trial details
Biological sex: AllType: ObservationalSponsor: AstraZenecaUpdated: May 15, 2026Locations: 4
Eligibility criteria

Not listed

Status: Recruiting

Lysosomal Acid Lipase (LAL) Deficiency Registry

This is an observational, multi-center, international disease registry designed to collect longitudinal data and create a knowledge base that will be utilized to improve the care and treatment of patients with LAL Deficiency. Participation in the Registry by both physicians and patients is voluntary.

Participants needed: 300
Trial details
Biological sex: AllType: ObservationalSponsor: Alexion Pharmaceuticals, Inc.Updated: Mar 6, 2026Locations: 104Duration: 10 Years
Eligibility criteria

Not listed